|
|
Article: Drug-Eluting Stents Beat Bare Metal Stents in Diabetics.(Clinical report)
- Article from:
- Life Science Weekly
- Article date:
- November 25, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Drug-eluting stents reduced the risk of revascularization, heart attack and death in diabetics as compared with bare-metal stents in the largest observational comparison, researchers reported at the American Heart Association's Scientific Sessions 2008. The results from The Drug-eluting and Bare Metal Stenting in Patients with Diabetes Mellitus: Results from the Mass-DAC Registry, were presented as a late-breaking clinical trial. The study is simultaneously published in Circulation: Journal of the American Heart Association (see also Heart Attack).
"We actually saw a significant benefit from using drug-eluting stents in this patient population," said Laura Mauri, ...